"Designing Growth Strategies is in our DNA"

In-vitro Diagnostics (IVD) Market Size, Share & Industry Analysis, By Product Type (Instruments and Reagents & Consumables), By Technique (Immunodiagnostics [Enzyme Linked Immunosorbent Assay, Fluorescence immunoassay, Rapid test], Clinical Chemistry, Molecular Diagnostics, Hematology), By Sample (Blood, Urine, Saliva, Tissue), By Setting (Laboratories, Point-of-Care), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Allergy), By End-user (Clinical Laboratories, Hospitals, Physician’s Offices), & Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI101443

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 6.1% from 2025-2032

Unit

Value (USD Billion)

Segmentation

By Product Type

  • Instruments
  • Reagents & Consumables

By Technique

  • Immunodiagnostics
    • Enzyme-linked immunosorbent Assays (ELISA)
    • Fluorescence immunoassay (FIA)
    • Rapid test
    • Others
  • Clinical Chemistry
  • Electrolyte Panel
  • Basic and Comprehensive Metabolic Panels
  • Liver Tests
  • Renal Tests
  • Lipid Panel
  • Others
  • Molecular Diagnostics
    • Polymerase Chain Reaction (PCR)
    • In Situ Hybridization
    • DNA Sequencing & Next-Generation Sequencing
    • Others
  • Hematology
  • Others

By Sample

  • Blood
  • Urine
  • Saliva
  • Tissue
  • Others

By Setting

  • Laboratories
  • Point-of-Care

By Application

  • Infectious Diseases
  • Cardiology
  • Oncology
  • Gastroenterology
  • Allergy
  • Autoimmunity
  • Prenatal Screening
  • Others

By End-user

  • Clinical Laboratories
  • Hospitals
  • Physician’s Offices
  • Others

By Region

  • North America (By Product Type, By Technique, By Sample, By Setting, By Application, By End-user, and By Country)
    • U.S. (By Setting)
    • Canada (By Setting)
  • Europe (By Product Type, By Technique, By Sample, By Setting, By Application, By End-user, and By Country/Sub-region)
    • Germany (By Setting)
    • U.K. (By Setting)
    • France (By Setting)
    • Italy (By Setting)
    • Spain (By Setting)
    • Scandinavia (By Setting)
    • Rest of Europe (By Setting)
  • Asia Pacific (By Product Type, By Technique, By Sample, By Setting, By Application, By End-user, and By Country/Sub-region)
    • China (By Setting)
    • Japan (By Setting)
    • India (By Setting)
    • Australia (By Setting)
    • Southeast Asia (By Setting)
    • Rest of Asia Pacific (By Setting)
  • Latin America (By Product Type, By Technique, By Sample, By Setting, By Application, By End-user, and By Country/Sub-region)
    • Brazil (By Setting)
    • Mexico (By Setting)
    • Rest of Latin America (By Setting)
  • Middle East & Africa (By Product Type, By Technique, By Sample, By Setting, By Application, By End-user, and By Country/Sub-region)
    • South Africa (By Setting)
    • GCC (By Setting)
  • Rest of Middle East & Africa (By Setting)

 

  • 2019-2032
  • 2024
  • 2019-2023
  • 290
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann